Pathophysiology (Case Stduy)

Pathophysiology (Case Stduy)

Order Description

Case Study C

R.S. has smoked for many years and has developed hronic brénchitisfia chronic obstructive

pulmonary disease (COPD). He also has a history of Wease and peripheral arterial

vascular disease. His arterial blood gas (ABG) values are pH * 7.32 PaCO; = 60 l Hg PaO

74% zoxv-rzw

g f, Lff 50 mm Hg, HCO3-kffégIIgE Iris His hematocrit is 52% wrthriighnal red cell infice’s. e iésilismg anillrgyi:vre)

{page inhaled Bz agonist and 115635 lyhline to manage his respiratory disease. At this clinic Visit, it is

N f fiat noted on a chest X-ray that R.S. has an area of consolidation in his right lower lobe that is thought

(01 m 0&th be consistent with pneumonia.

Discussion Questions ‘7 7

1. What clinical findings are likely in R.S. as a consveguepcggofhis QQPD?

dim/1.1. brow l’itb dries; a {6:}!le . 0*5 ii? – f WWW

2. How would the consequences ofthe COPD of RS. (identified in question 1) differ from

those of emphysematous COPD?7; ; fl. , g, V

[org rel-(e of Ems/{3

3. Interpret R.S. ‘s laboratory results. How would his acid-base disorder be classified? What is f,

the most likely cause of his pplyeytlrierriiilii A ii 05%;? (El 042 g; 425′?

Hair; a Agwaé s are/$5; r2) Wit/TC v e ,;, [Life/r,

4. What is the rationale for treating R.S. with Theophylline and a 8; agonist? a

5. What effects would his respiratory disease have on his cardiovascular function?

i-n 1/ a ‘6 i/ l 35% Q /57( 3g. 77- 7S

[Hi-f: ,j/ié/bé/vrx’ (y ~ (fair

15:? 6,; A f i? 5 C

a , A

E r, ‘ » / i

7 l X) = j. Q » 2

r-W a ~ ; a

l f :WMW , ,.- ; .3 b j

l , ii’ i g» in?! ,Hyflfiwi

F 5:, 5 M} 5€³ {A} L z

g p inn .r

V/ _ Ln’z’riwéf

£52

r/ lg 3 ling? :5? +5? V ‘ ,4?

l; fl r A 7i. km 7g:

Ciel;

xxx,

(la/E? V :3?

J) 15/22 t

i; {3€² i l V{/}I_:-7:?;} .6

é; L’s/raw H X

Copyright © 2010, 2005, 2000, 1995 by Saunders, an imprint of Blsevier Inc.